Cargando…
COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer
BACKGROUND: Human pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal malignancies in the world and despite great efforts in research types of treatment remain limited. A frequently detected alteration in PDACs is a truncated O-linked N-acetylgalactosamine (GalNAc) glyco...
Autores principales: | Hofmann, Bianca T., Schlüter, Laura, Lange, Philip, Mercanoglu, Baris, Ewald, Florian, Fölster, Aljonna, Picksak, Aeint-Steffen, Harder, Sönke, El Gammal, Alexander T., Grupp, Katharina, Güngör, Cenap, Drenckhan, Astrid, Schlüter, Hartmut, Wagener, Christoph, Izbicki, Jakob R., Jücker, Manfred, Bockhorn, Maximilian, Wolters-Eisfeld, Gerrit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447007/ https://www.ncbi.nlm.nih.gov/pubmed/26021314 http://dx.doi.org/10.1186/s12943-015-0386-1 |
Ejemplares similares
-
Loss of complex O-glycosylation impairs exocrine pancreatic function and induces MODY8-like diabetes in mice
por: Wolters-Eisfeld, Gerrit, et al.
Publicado: (2018) -
Unmasking metabolic dependencies in pancreatic cancer: aberrant polyamine synthesis as a promising new therapeutic target
por: Wolters-Eisfeld, Gerrit, et al.
Publicado: (2023) -
Cosmc converter
por: Williams, Ruth
Publicado: (2006) -
Cosmc controls B cell homing
por: Zeng, Junwei, et al.
Publicado: (2020) -
FOXO1 overexpression and loss of pSerine256-FOXO1 expression predicts clinical outcome in esophageal adenocarcinomas
por: Grupp, Katharina, et al.
Publicado: (2018)